Dr. Serkan Aygın 4000 Grafts: May 2023 Patient Case
Patient case archive: This page documents a reported 4,000-graft hair transplant associated with Serkan Aygın Clinic, dated 16 May 2023.
Archive Information and Verification
This is an archived patient-reported record, not a clinical study or a measure of the clinic’s average outcomes. This editorial update does not independently verify the original source, photographs, exact graft count or current clinic workflow.
The operation date and the latest photograph date should be read from the recorded case details below. Where a date or follow-up is not recorded, do not infer it from the article’s publication date or an image filename. Early healing photos do not establish final growth.
Compare this entry with our patient archive and guide to evaluating patient reviews. Editorial context updated: 12 October 2026.
Case summary
- Clinic: Serkan Aygın
- Grafts: 4,000
- Procedure date: 16 May 2023
- Patient concern: whether finasteride/Proscar is necessary after transplant
The medication question below comes from the patient’s original account. It should not be read as proof that finasteride or any other medication is required for transplanted grafts to grow. Medication decisions depend on the patient’s broader hair-loss pattern, medical history and clinician assessment. For background, see our finasteride guide and hair transplant reviews guide.
How to interpret this patient case
This page is an archived patient case rather than a controlled clinical study. Graft count, technique, timing, pricing and patient impressions should be read as historical case details only where they were recorded in the original account. Hair-transplant outcomes vary with donor density, hair calibre, recipient-area size, surgical planning, healing and the progression of future hair loss.
This page records a reported 4,000-graft procedure dated 16 May 2023 and includes a patient question about finasteride/Proscar after transplantation. The question is not a recommendation. Medication decisions depend on individual circumstances and belong with a clinician; the gallery should be interpreted using the dates and areas shown.
Useful Points to Compare
- Starting hair-loss pattern and donor density
- Reported graft count and recipient-area coverage
- Donor extraction pattern and visible thinning
- Hairline design, direction and density distribution
- Time elapsed between surgery and each photograph
Patient question after the procedure
The patient’s main concern after surgery was whether finasteride or Proscar was necessary for the transplanted hair to grow well and remain permanent. The question also reflected uncertainty about whether medication changes the final result itself or mainly affects the progression of ongoing native-hair loss.
That distinction matters. A hair transplant moves follicles from the donor area, while medications such as finasteride are generally discussed in the context of managing androgenetic hair loss in existing native hair. Whether treatment is appropriate is an individual medical decision rather than a requirement that can be inferred from this case alone.
Important Distinction: Native Hair and Transplanted Hair
The patient’s medication question should be discussed with a qualified clinician. Finasteride is generally used to address ongoing androgenetic hair loss; the need for treatment cannot be determined from graft count or postoperative photographs alone. Any potential benefits must be weighed against contraindications and adverse effects for the individual patient.
What is useful about this case?
- The procedure date and reported graft count are clear.
- The case captures a common post-transplant question about medication.
- The photo set can be compared with the starting pattern and later stages if follow-up images are available.
- The patient’s medication question should be separated from the cosmetic assessment of the transplant itself.
For more context, see our finasteride guide, hair transplant techniques guide and patient case archive.
